These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16186958)
1. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma. Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958 [TBL] [Abstract][Full Text] [Related]
2. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors. Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457 [TBL] [Abstract][Full Text] [Related]
4. Assessment of staging, prognosis and mortality of colorectal cancer by tumor markers: receptor erbB-2 and cadherins. Jesus EC; Matos D; Artigiani R; Waitzberg AF; Goldenberg A; Saad SS Acta Cir Bras; 2005; 20(6):422-7. PubMed ID: 16302076 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742 [TBL] [Abstract][Full Text] [Related]
6. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1). Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199 [TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival. Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889 [TBL] [Abstract][Full Text] [Related]
9. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853 [TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study. Batista WR; Santos G; Vital FMR; Matos D Sao Paulo Med J; 2019 May; 137(1):33-38. PubMed ID: 31116268 [TBL] [Abstract][Full Text] [Related]
12. [Variation in the prognostic value of p53 protein in relation to tumoral stage in patients with colorectal adenocarcinoma]. Díez M; Pollán M; Ramos P; Villeta R; Ratia T; Hernández P; Lozano O; Noguerales F; Granell J Cir Esp; 2005 Apr; 77(4):213-20. PubMed ID: 16420920 [TBL] [Abstract][Full Text] [Related]
14. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma. Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048 [TBL] [Abstract][Full Text] [Related]
15. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas. Manne U; Weiss HL; Grizzle WE Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204 [TBL] [Abstract][Full Text] [Related]
16. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting. Borre M; Stausbol-Gron B; Overgaard J J Urol; 2000 Sep; 164(3 Pt 1):716-21. PubMed ID: 10953132 [TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of bcl-2 and p53 protein expression in pancreatic carcinomas. Ohshio G; Suwa H; Imamura T; Yamaki K; Tanaka T; Hashimoto Y; Imamura M Scand J Gastroenterol; 1998 May; 33(5):535-9. PubMed ID: 9648995 [TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703 [TBL] [Abstract][Full Text] [Related]
19. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer. Kaklamanis L; Savage A; Whitehouse R; Doussis-Anagnostopoulou I; Biddolph S; Tsiotos P; Mortensen N; Gatter KC; Harris AL Br J Cancer; 1998 Jun; 77(11):1864-9. PubMed ID: 9667660 [TBL] [Abstract][Full Text] [Related]
20. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]